OBP-801
- Generic Name
- OBP-801
- Drug Type
- Small Molecule
- Chemical Formula
- C20H31N3O6S2
- CAS Number
- 328548-11-4
- Unique Ingredient Identifier
- 30Q3VS5HZ4
- Background
OBP-801 has been used in trials studying the treatment of Solid Tumor.
A Dose-Escalation Study of OBP-801 in Patients With Advanced Solid Tumors
- First Posted Date
- 2015-04-10
- Last Posted Date
- 2019-03-13
- Lead Sponsor
- Oncolys BioPharma Inc
- Target Recruit Count
- 17
- Registration Number
- NCT02414516
- Locations
- 🇺🇸
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath